Structured evidence table for Propolis Immune Support Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Propolis Immune Support Randomized Trial | However, these modalities, particularly chemotherapy and radiotherapy, are associated with significant adverse effects, especially in tissues with a high cell turnover, such as the oral epithelium []. | 3 | Assis Matheus de Morais (2026) | Clinical Evidence on the Use of Propolis for Oral Mucositis |
| Propolis Immune Support Randomized Trial | When induced by chemotherapy, OM typically manifests during the first week of treatment, peaking around the eighth day; in radiotherapy-associated cases, severity usually increases from the second week onward []. | 3 | Assis Matheus de Morais (2026) | Clinical Evidence on the Use of Propolis for Oral Mucositis |
| Propolis Immune Support Randomized Trial | Although reviews addressing the use of propolis in OM management are available, the present review differs by focusing exclusively on evidence derived from contemporary clinical trials and by providing a structured analysis of the different pharmaceutical formulations in relation to clinical efficacy. | 3 | Assis Matheus de Morais (2026) | Clinical Evidence on the Use of Propolis for Oral Mucositis |
| Propolis Immune Support Randomized Trial | 1 2 3 4 5 Cancer is a malignant neoplasm resulting from genomic alterations and disruptions in the regulatory mechanisms of the cell cycle []. | 3 | Assis Matheus de Morais (2026) | Clinical Evidence on the Use of Propolis for Oral Mucositis |
| Propolis Immune Support Randomized Trial | Obesity develops as a result of the combined influence of genetic factors, social and economic conditions, and cultural lifestyle patterns. | 3 | İmre Kadriye Elif (2026) | Propolis in Obesity and Related Metabolic Disorders: Mechanistic and Clinical Insights—A Scoping Review |
| Propolis Immune Support Randomized Trial | 8 3 8 9 10 The treatment of obesity relies on a range of evidence-based options. | 3 | İmre Kadriye Elif (2026) | Propolis in Obesity and Related Metabolic Disorders: Mechanistic and Clinical Insights—A Scoping Review |
| Propolis Immune Support Randomized Trial | These include behavioral and dietary approaches, increased physical activity, drug therapy, and metabolic or bariatric surgery []. | 3 | İmre Kadriye Elif (2026) | Propolis in Obesity and Related Metabolic Disorders: Mechanistic and Clinical Insights—A Scoping Review |
| Propolis Immune Support Randomized Trial | 1 2 3 The World Health Organization describes obesity as an excessive build-up of body fat that can endanger health. | 3 | İmre Kadriye Elif (2026) | Propolis in Obesity and Related Metabolic Disorders: Mechanistic and Clinical Insights—A Scoping Review |
Source documents